Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Mertz, Dominik ^a   Viktorin, Nina ^a   Wolbers, Marcel ^b   Laifer, Gerd ^a   Leimenstoll, Bernd ^a   Fluckiger, Ursula ^a   Battegay, Manuel ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; FLUCLOXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TUBERCULOSTATIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATTITUDE TO HEALTH; CANDIDIASIS; CLINICAL EVALUATION; ENDOCARDITIS; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PNEUMONIA; PRACTICE GUIDELINE; RELAPSE; SEPSIS; SINUSITIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; THROMBOSIS; TREATMENT OUTCOME; TUBERCULOSIS; UNIVERSITY HOSPITAL; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; ADOLESCENT; COMMUNICABLE DISEASE; DRUG COMBINATION; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE; SWITZERLAND;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND;

EID: 42549098072     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-42     Document Type: Article

References (45)

1. Bassetti S Hoffmann M Bucher HC Fluckiger U Battegay M Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program Clin Infect Dis 2002, 34(5):711-713. 10.1086/338876 11807681
2. Binswanger IA Kral AH Bluthenthal RN Rybold DJ Edlin BR High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco Clin Infect Dis 2000, 30(3):579-581. 10.1086/ 313703 10722447
3. Scheidegger C Zimmerli W Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland Reviews of infectious diseases 1989, 11(3):486-493. 2749105
4. Palepu A Tyndall MW Leon H Muller J O'Shaughnessy MV Schechter MT Anis AH Hospital utilization and costs in a cohort of injection drug users Cmaj 2001, 165(4):415-420. 81365 11531049
5. Louria DB Hensle T Rose J The major medical complications of heroin addiction Annals of internal medicine 1967, 67(1):1-22. 5339228
6. Cherubin CE Sapira JD The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later Annals of internal medicine 1993, 119(10):1017-1028. 8214979
7. Gordon RJ Lowy FD Bacterial infections in drug users The New England journal of medicine 2005, 353(18):1945-1954. 10.1056/NEJMra042823 16267325
8. Hind CR Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications Thorax 1990, 45(12):957-961. 462846 2281430
9. Murphy EL DeVita D Liu H Vittinghoff E Leung P Ciccarone DH Edlin BR Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study Clin Infect Dis 2001, 33(1):35-40. 10.1086/ 320879 11389492
10. Stein MD Anderson B Injection frequency mediates health service use among persons with a history of drug injection Drug and alcohol dependence 2003, 70(2):159-168. 10.1016/S0376-8716(02)00344-7
11. Sendi P Hoffmann M Bucher HC Erb P Haller P Gyr N Battegay M Intravenous opiate maintenance in a cohort of injecting drug addicts Drug and alcohol dependence 2003, 69(2):183-188. 10.1016/S0376-8716(02)00316-2
12. Dans PE Matricciani RM Otter SE Reuland DS Intravenous drug abuse and one academic health center Jama 1990, 263(23):3173-3176. 10.1001/ jama.263.23.3173 2348527
13. Dausey DJ Desai RA Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse The Journal of nervous and mental disease 2003, 191(1):10-17. 10.1097/ 00005053-200301000-00003
14. Jacob R Clare IC Holland A Watson PC Maimaris C Gunn M Self-harm, capacity, and refusal of treatment: Implications for emergency medical practice. A prospective observational study Emerg Med J 2005, 22(11):799-802. 10.1136/emj.2004.018671 16244339
15. Seaborn Moyse H Osmun WE Discharges against medical advice: A community hospital's experience Can J Rural Med 2004, 9(3):148-153. 15603687
16. Stevens DL Bisno AL Chambers HF Everett ED Dellinger P Goldstein EJ Gorbach SL Hirschmann JV Kaplan EL Montoya JG Wade JC Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clin Infect Dis 2005, 41(10):1373-1406. 10.1086/497143 16231249
17. Woodhead M Blasi F Ewig S Huchon G Ieven M Ortqvist A Schaberg T Torres A van der Heijden G Verheij TJ Guidelines for the management of adult lower respiratory tract infections Eur Respir J 2005, 26(6):1138-1180. 10.1183/09031936.05.00055705 16319346
18. Durack DT Lukes AS Bright DK New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service The American journal of medicine 1994, 96(3):200-209. 10.1016/0002-9343(94)90143-0 8154507
19. Fah F Zimmerli W Jordi M Schoenenberger RA Septic deep venous thrombosis in intravenous drug users Swiss Med Wkly 2002, 132(27-28):386-392. 12428193
20. Mertz D Khanlari B Viktorin N Battegay M Fluckiger U Intravenous antibiotic treatment of less than 28 days is sufficient for suppurative thrombophlebitis in intravenous drug users Clin Infect Dis; 2008. 18233950
21. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992, 101(6):1644-1655. 10.1378/chest.101.6.1644 1303622
22. Horan TC Gaynes RP Hospital Epidemiology and Infection Control Philadelphia:LIppincott Williams & Wilkins Mayhall CG 3rd edition, 2004:1659-1702.
23. Mermel LA Farr BM Sherertz RJ Raad O'Grady N Harris JS Craven DE Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 2001, 32(9):1249-1272. 10.1086/320001 11303260
24. Baddour LM Wilson WR Bayer AS Fowler VG Jr. Bolger AF Levison ME Ferrieri P Gerber MA Tani LY Gewitz MH Tong DC Steckelberg JM Baltimore RS Shulman ST Burns JC Falace DA Newburger JW Pallasch TJ Takahashi M Taubert KA Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation 2005. 111(23):e394-434. 10.1161/ CIRCULATIONAHA.105.165564 15956145
25. Dworkin RJ Lee BL Sande MA Chambers HF Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin Lancet 1989, 2(8671):1071-1073. 10.1016/ S0140-6736(89)91083-0 2572799
26. Diamantis I Bassetti S Erb P Ladewig D Gyr K Battegay M High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts Journal of hepatology 1997, 26(4):794-797. 10.1016/ S0168-8278(97)80244-9 9126791
27. Bassetti S Battegay M Furrer H Rickenbach M Flepp M Kaiser L Telenti A Vernazza PL Bernasconi E Sudre P Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study Journal of acquired immune deficiency syndromes (1999) 1999, 21(2):114-119. 10360802
28. Glass TR De Geest S Weber R Vernazza PL Rickenbach M Furrer H Bernasconi E Cavassini M Hirschel B Battegay M Bucher HC Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: The Swiss HIV Cohort Study Journal of acquired immune deficiency syndromes (1999) 2006, 41(3):385-392. 10.1097/ 01.qai.0000186371.95301.52 16540942
29. Joe GW Simpson DD Mortality rates among opioid addicts in a longitudinal study American journal of public health 1987, 77(3):347-348. 1646911 3812844
30. Fowler VG Jr. Miro JM Hoen B Cabell CH Abrutyn E Rubinstein E Corey GR Spelman D Bradley SF Barsic B Pappas PA Anstrom KJ Wray D Fortes CQ Anguera I Athan E Jones P van der Meer JT Elliott TS Levine DP Bayer AS Staphylococcus aureus endocarditis: A consequence of medical progress Jama 2005, 293(24):3012-3021. 10.1001/jama.293.24.3012 15972563
31. Hecht SR Berger M Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes Annals of internal medicine 1992, 117(7):560-566. 1524330
32. Martin-Davila P Navas E Fortun J Moya JL Cobo J Pintado V Quereda C Jimenez-Mena M Moreno S Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size American heart journal 2005, 150(5):1099-1106. 10.1016/j.ahj.2005.02.009 16291005
33. Ruotsalainen E Sammalkorpi K Laine J Huotari K Sarna S Valtonen V Jarvinen A Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: A prospective study of 74 patients BMC infectious diseases 2006, 6:137. 1584240 16965625 10.1186/1471-2334-6-137
34. Bergstein JM Baker EJ Aprahamian C Schein M Wittmann DH Soft tissue abscesses associated with parenteral drug abuse: Presentation, microbiology, and treatment The American surgeon 1995, 61(12):1105-1108. 7486458
35. Bassetti S Battegay M Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies Infection 2004, 32(3):163-169. 10.1007/s15010-004-3106-0 15188077
36. Crane LR Levine DP Zervos MJ Cummings G Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy Reviews of infectious diseases 1986, 8(3):364-373. 3636987
37. Wilson LE Thomas DL Astemborski J Freedman TL Vlahov D Prospective study of infective endocarditis among injection drug users The Journal of infectious diseases 2002, 185(12):1761-1766. 10.1086/340827 12085322
38. Summanen PH Talan DA Strong C McTeague M Bennion R Thompson JE Jr. Vaisanen ML Moran G Winer M Finegold SM Bacteriology of skin and soft-tissue infections: Comparison of infections in intravenous drug users and individuals with no history of intravenous drug use Clin Infect Dis 1995, 20(Suppl 2):S279-82. 7548575
39. Fleisch F Oechslin EC Gujer AR Ritzler E Imhof A Ruef C Reinhart WH Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland Infection 2005, 33(4):273-277. 10.1007/s15010-005-4149-6 16091899
40. Kluytmans J van Belkum A Verbrugh H Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks Clinical microbiology reviews 1997, 10(3):505-520. 172932 9227864
41. Bassetti S Wolfisberg L Jaussi B Frei R Kuntze MF Battegay M Widmer AF Carriage of Staphylococcus aureus among injection drug users: Lower prevalence in an injection heroin maintenance program than in an oral methadone program Infect Control Hosp Epidemiol 2004, 25(2):133-137. 10.1086/502364 14994939
42. Mertz D Frei R Jaussi B Tietz A Stebler C Fluckiger U Widmer AF Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus Clin Infect Dis 2007, 45(4):475-477. 10.1086/520016 17638197
43. Mettler J SM Sendi P, Widmer AF, Bingisser R, Battegay M, Fluckiger U, Bassetti S Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: A prospective observational study BMC infectious diseases 2007, 7(21):1847433 17386104
44. Zinkernagel C Naef MR Bucher HC Ladewig D Gyr N Battegay M Onset and pattern of substance use in intravenous drug users of an opiate maintenance program Drug and alcohol dependence 2001, 64(1):105-109. 10.1016/S0376-8716(00)00221-0
45. Armstrong GL Injection drug users in the United States, 1979-2002: An aging population Archives of internal medicine 2007, 167(2):166-173. 10.1001/archinte.167.2.166 17242318